Screener
Fulgent Genetics, Inc. FLGT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss attributable to noncontrolling interests | 448 | 369 |
| Net loss attributable to Fulgent | $(24,826) | $(11,530) |
| Net loss per common share attributable to Fulgent | ||
| Basic | $(0.80) | $(0.37) |
| Diluted | $(0.80) | $(0.37) |
| Weighted-average common shares: | ||
| Basic | 30,881 | 30,832 |
| Diluted | 30,881 | 30,832 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s shares (diluted)?
- Fulgent Genetics, Inc. (FLGT) reported shares (diluted) of 30.9M in Q1 2026.
- How has Fulgent Genetics, Inc.'s shares (diluted) changed year-over-year?
- Fulgent Genetics, Inc.'s shares (diluted) increased by 0.2% year-over-year, from 30.8M to 30.9M.
- What is the long-term trend for Fulgent Genetics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s shares (diluted) has grown at a -0.2% compound annual growth rate (CAGR), from 123.7M to 122.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Fulgent Genetics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude